Back to School: How biopharma can reboot drug development. Access exclusive analysis here
The Geomatrix controlled-release formulation of the drug was developed by Genta Jago, a joint venture between GNTA (San Diego) and Jagotec AG.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury